期刊文献+

特发性肺纤维化急性加重的最新研究进展 被引量:2

Recent advances in acute exacerbation of idiopathic pulmonary fibrosis
原文传递
导出
摘要 特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是一种病因不明的慢性进展性纤维化型间质性肺炎,组织学表现为普通型间质性肺炎.IPF通常是缓慢进展,但部分IPF患者可以出现急剧、原因不明的临床明显恶化,称之为IPF急性加重.IPF急性加重难以预测、病死率高、缺乏有效的治疗措施.本文就近年来IPF急性加重的发病率、危险因素、病理生理、发病机制、诊断和治疗等方面的研究进展进行综述. Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic,progressive fibrosing interstitial pneumonia of unknown cause,characterized by a histological pattern of usual interstitial pneumonia.The clinical course of IPF is usually chronic,but some patients may experience episodes of acute respiratory worsening.These episodes of idiopathic acute deterioration have been termed as acute exacerbations of IPF (AE-IPF).AE-IPF may be less predictable,associated with a high mortality rate and no effective therapy.This article reviews the incidence,risk factors,pathophysiology,pathogenesis,diagnosis and treatment progress in AE-IPF.
出处 《国际呼吸杂志》 2013年第13期1028-1034,共7页 International Journal of Respiration
关键词 特发性肺纤维化 急性加重 生物标记 治疗 Idiopathic pulmonary fibrosis Acute exacerbation Biomarkers Treatment
  • 相关文献

参考文献42

  • 1Raghu G, Collard HR, Egan JJ,et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med,2011,183:788-824.
  • 2Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med,2007,176:636-643.
  • 3Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J,2008,32:170-174.
  • 4Song JW, Hong SB, Lira CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J, 2011,37 : 356-363.
  • 5Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis:frequency and clinical features. Eur Respir J, 2006,27 : 143-150.
  • 6Kim DS, Collard HR, King TE Jr. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc, 2006,3 : 285-292.
  • 7Takeda A, Enomoto T, Sanuki N, et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered byhypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med, 2008,26 : 504-507.
  • 8Churg A, Mtiller NL, Silva CI, et al. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol, 2007, 31 :277-284.
  • 9Kaarteenaho R, Kinnula VL. Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders. Pulm Med,2011,2011 :531302.
  • 10Parambil JG, Myers JL, Aubry MC, et al. Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest,2007,132:50-57.

同被引文献27

  • 1Cottin V. The impact of emphysema in pulmonary fibrosis[J]. Eur Respir Rev, 2013, 22(128): 153-157.
  • 2Hanaoka M, Ito M, Droma Y, et al. Comparison of gene expression profiling between lung fibrotic and emphysematous tissues sampled from patients with combined pulmonary fibrosis and emphysema[J]. Fibrogenesis Tissue Repair, 2012, 5(1): 17-26.
  • 3Papiris SA, Triantafillidou C, Manali ED, et al. Combined pulmonary fibrosis and emphysema[J]. Expert Rev Respir Med, 2013, 7(1): 19-32.
  • 4Ryerson C J, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis[J]. Chest, 2013, 144(1): 234-240.
  • 5Jankowich MD, Rounds SI. Combined pulmonary fibrosis and emphysema syndrome" a review[J]. Chest, 2012, 141(1): 222-231.
  • 6Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2007, 176(6): 532-555.
  • 7Antoniou KM, Wells AU. Acute exacerbations of idiopathic pulmonary fibrosis[J]. Respiration, 2013, 86(4) 265-274.
  • 8Lloyd CR, Walsh SL, Hansell DM. High-resolution CT of complications of idiopathic fibrotic lung disease[J]. Br J Radiol, 2011, 84(1003): 581-592.
  • 9Horita N, Akahane M, Okada Y, et al. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis[J]. Intern Med, 2011, 50(3): 189-195.
  • 10Saranathan R, Sudhakar P, Karthika RU, et al. Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids[J]. Indian J Med Res, 2014, 140(2): 262-270.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部